Effects of a multidrug chemotherapy regimen on the thymus

G. A. Perry, J. D. Jackson, James E Talmadge

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Multidrug chemotherapy regimens are commonly used in the treatment of cancer. The dose limiting tissue for chemotherapeutic treatment is often the bone marrow, as many chemotherapeutic agents selectively target rapidly proliferating cells. Bone marrow transplantation (BMT) has allowed an increase in chemotherapeutic dose; however, this type of therapy is associated with a prolonged suppression of immune function following the BMT. Although it may be possible to augment this immune function, animal models which can be used to test various cytokines have not been well described. We have developed a mouse model of multi-drug chemotherapy which, like the human, demonstrates long term immune suppression following BMT. In this report, we describe the specific effects of this chemotherapy regimen on T cell differentiation in the thymus of treated mice using three color FACS analysis. Results demonstrated that specific populations of thymocytes are extremely susceptible to chemotherapeutic insult. Both thymus cellularity and the immature CD3-CD4+CD8+ double positive population dropped to approximately 3% of their original values by 7 days after chemotherapy initiation. During the same time period, cells expressing both αβ and γδ T cell receptors demonstrated a 2-6 fold increase in frequency. Similar results were observed for the αβ+CD4-CD8- population of natural suppressor cells. Long-term changes in the proportion of cells expressing the Vβ5 TCR were also observed following chemotherapy. These results demonstrate that chemotherapy regimens may directly influence T cell differentiation within the thymus, and also suggest that long term changes in the T cell Vβ repertoire may occur following chemotherapy.

Original languageEnglish (US)
Pages (from-to)39-51
Number of pages13
JournalThymus
Volume23
Issue number1
StatePublished - Jan 1 1994

Fingerprint

Thymus Gland
Drug Therapy
Bone Marrow Transplantation
T-Lymphocytes
Cell Differentiation
Population
Thymocytes
T-Cell Antigen Receptor
Therapeutics
Animal Models
Color
Bone Marrow
Cytokines
Pharmaceutical Preparations
Neoplasms

Keywords

  • Bone marrow transplantation
  • Chemotherapy
  • FACS
  • T-cell receptor
  • Thymocytes
  • Thymus

ASJC Scopus subject areas

  • Immunology

Cite this

Perry, G. A., Jackson, J. D., & Talmadge, J. E. (1994). Effects of a multidrug chemotherapy regimen on the thymus. Thymus, 23(1), 39-51.

Effects of a multidrug chemotherapy regimen on the thymus. / Perry, G. A.; Jackson, J. D.; Talmadge, James E.

In: Thymus, Vol. 23, No. 1, 01.01.1994, p. 39-51.

Research output: Contribution to journalArticle

Perry, GA, Jackson, JD & Talmadge, JE 1994, 'Effects of a multidrug chemotherapy regimen on the thymus', Thymus, vol. 23, no. 1, pp. 39-51.
Perry, G. A. ; Jackson, J. D. ; Talmadge, James E. / Effects of a multidrug chemotherapy regimen on the thymus. In: Thymus. 1994 ; Vol. 23, No. 1. pp. 39-51.
@article{920e5ca9148d421d8c9a2818610f0b13,
title = "Effects of a multidrug chemotherapy regimen on the thymus",
abstract = "Multidrug chemotherapy regimens are commonly used in the treatment of cancer. The dose limiting tissue for chemotherapeutic treatment is often the bone marrow, as many chemotherapeutic agents selectively target rapidly proliferating cells. Bone marrow transplantation (BMT) has allowed an increase in chemotherapeutic dose; however, this type of therapy is associated with a prolonged suppression of immune function following the BMT. Although it may be possible to augment this immune function, animal models which can be used to test various cytokines have not been well described. We have developed a mouse model of multi-drug chemotherapy which, like the human, demonstrates long term immune suppression following BMT. In this report, we describe the specific effects of this chemotherapy regimen on T cell differentiation in the thymus of treated mice using three color FACS analysis. Results demonstrated that specific populations of thymocytes are extremely susceptible to chemotherapeutic insult. Both thymus cellularity and the immature CD3-CD4+CD8+ double positive population dropped to approximately 3{\%} of their original values by 7 days after chemotherapy initiation. During the same time period, cells expressing both αβ and γδ T cell receptors demonstrated a 2-6 fold increase in frequency. Similar results were observed for the αβ+CD4-CD8- population of natural suppressor cells. Long-term changes in the proportion of cells expressing the Vβ5 TCR were also observed following chemotherapy. These results demonstrate that chemotherapy regimens may directly influence T cell differentiation within the thymus, and also suggest that long term changes in the T cell Vβ repertoire may occur following chemotherapy.",
keywords = "Bone marrow transplantation, Chemotherapy, FACS, T-cell receptor, Thymocytes, Thymus",
author = "Perry, {G. A.} and Jackson, {J. D.} and Talmadge, {James E}",
year = "1994",
month = "1",
day = "1",
language = "English (US)",
volume = "23",
pages = "39--51",
journal = "Thymus",
issn = "0165-6090",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Effects of a multidrug chemotherapy regimen on the thymus

AU - Perry, G. A.

AU - Jackson, J. D.

AU - Talmadge, James E

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Multidrug chemotherapy regimens are commonly used in the treatment of cancer. The dose limiting tissue for chemotherapeutic treatment is often the bone marrow, as many chemotherapeutic agents selectively target rapidly proliferating cells. Bone marrow transplantation (BMT) has allowed an increase in chemotherapeutic dose; however, this type of therapy is associated with a prolonged suppression of immune function following the BMT. Although it may be possible to augment this immune function, animal models which can be used to test various cytokines have not been well described. We have developed a mouse model of multi-drug chemotherapy which, like the human, demonstrates long term immune suppression following BMT. In this report, we describe the specific effects of this chemotherapy regimen on T cell differentiation in the thymus of treated mice using three color FACS analysis. Results demonstrated that specific populations of thymocytes are extremely susceptible to chemotherapeutic insult. Both thymus cellularity and the immature CD3-CD4+CD8+ double positive population dropped to approximately 3% of their original values by 7 days after chemotherapy initiation. During the same time period, cells expressing both αβ and γδ T cell receptors demonstrated a 2-6 fold increase in frequency. Similar results were observed for the αβ+CD4-CD8- population of natural suppressor cells. Long-term changes in the proportion of cells expressing the Vβ5 TCR were also observed following chemotherapy. These results demonstrate that chemotherapy regimens may directly influence T cell differentiation within the thymus, and also suggest that long term changes in the T cell Vβ repertoire may occur following chemotherapy.

AB - Multidrug chemotherapy regimens are commonly used in the treatment of cancer. The dose limiting tissue for chemotherapeutic treatment is often the bone marrow, as many chemotherapeutic agents selectively target rapidly proliferating cells. Bone marrow transplantation (BMT) has allowed an increase in chemotherapeutic dose; however, this type of therapy is associated with a prolonged suppression of immune function following the BMT. Although it may be possible to augment this immune function, animal models which can be used to test various cytokines have not been well described. We have developed a mouse model of multi-drug chemotherapy which, like the human, demonstrates long term immune suppression following BMT. In this report, we describe the specific effects of this chemotherapy regimen on T cell differentiation in the thymus of treated mice using three color FACS analysis. Results demonstrated that specific populations of thymocytes are extremely susceptible to chemotherapeutic insult. Both thymus cellularity and the immature CD3-CD4+CD8+ double positive population dropped to approximately 3% of their original values by 7 days after chemotherapy initiation. During the same time period, cells expressing both αβ and γδ T cell receptors demonstrated a 2-6 fold increase in frequency. Similar results were observed for the αβ+CD4-CD8- population of natural suppressor cells. Long-term changes in the proportion of cells expressing the Vβ5 TCR were also observed following chemotherapy. These results demonstrate that chemotherapy regimens may directly influence T cell differentiation within the thymus, and also suggest that long term changes in the T cell Vβ repertoire may occur following chemotherapy.

KW - Bone marrow transplantation

KW - Chemotherapy

KW - FACS

KW - T-cell receptor

KW - Thymocytes

KW - Thymus

UR - http://www.scopus.com/inward/record.url?scp=0028104737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028104737&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 39

EP - 51

JO - Thymus

JF - Thymus

SN - 0165-6090

IS - 1

ER -